These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Methylenetetrahydrofolate reductase C677T polymorphism and diabetic retinopathy risk: a meta-analysis of the Chinese population. Xu WH, Zhuang Y, Han X, Yuan ZL. J Int Med Res; 2020 Jan; 48(1):300060518816834. PubMed ID: 30628508 [Abstract] [Full Text] [Related]
4. Methylenetrahydrofolate Reductase Gene C677T Polymorphism and Diabetic Retinopathy: a Meta-Analysis. Shen C, Zhao M, Li YY, Liu NP. Chin Med Sci J; 2020 Mar 31; 35(1):71-84. PubMed ID: 32299540 [Abstract] [Full Text] [Related]
5. Methylenetetrahydrofolate reductase C677T polymorphism and type 2 diabetes mellitus in Chinese population: a meta-analysis of 29 case-control studies. Zhu B, Wu X, Zhi X, Liu L, Zheng Q, Sun G. PLoS One; 2014 Mar 31; 9(7):e102443. PubMed ID: 25047451 [Abstract] [Full Text] [Related]
6. Association between methylenetetrahydrofolate reductase C677T polymorphism and psoriasis: A meta-analysis. Wu D, Shi D, Yang L, Zhu X. J Dermatol; 2016 Feb 31; 43(2):162-9. PubMed ID: 26212228 [Abstract] [Full Text] [Related]
7. Association of MTHFR C677T polymorphism and type 2 diabetes mellitus (T2DM) susceptibility. Meng Y, Liu X, Ma K, Zhang L, Lu M, Zhao M, Guan MX, Qin G. Mol Genet Genomic Med; 2019 Dec 31; 7(12):e1020. PubMed ID: 31663297 [Abstract] [Full Text] [Related]
9. Association between MTHFR C677T polymorphism and depression: An updated meta-analysis of 26 studies. Wu YL, Ding XX, Sun YH, Yang HY, Chen J, Zhao X, Jiang YH, Lv XL, Wu ZQ. Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct 01; 46():78-85. PubMed ID: 23831680 [Abstract] [Full Text] [Related]
10. Association between MTHFR C677T polymorphism and diabetic nephropathy in the Chinese population: An updated meta-analysis and review. Xiong X, Lin XK, Xiao X, Qin DP, Zhou DY, Hu JG, Liu Y, Zhong XS. Nephrology (Carlton); 2016 Jan 01; 21(1):5-12. PubMed ID: 26072975 [Abstract] [Full Text] [Related]
12. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and tumor risk: evidence from 134 case-control studies. Tang M, Wang SQ, Liu BJ, Cao Q, Li BJ, Li PC, Li YF, Qin C, Zhang W. Mol Biol Rep; 2014 Jul 01; 41(7):4659-73. PubMed ID: 24744129 [Abstract] [Full Text] [Related]
13. Association between MTHFR C677T polymorphism and depression: a meta-analysis in the Chinese population. Jiang W, Xu J, Lu XJ, Sun Y. Psychol Health Med; 2016 Sep 01; 21(6):675-85. PubMed ID: 26681493 [Abstract] [Full Text] [Related]
17. The methylenetetrahydrofolate reductase C677T polymorphism and breast cancer risk in Asian populations. Rai V. Asian Pac J Cancer Prev; 2014 Sep 01; 15(14):5853-60. PubMed ID: 25081713 [Abstract] [Full Text] [Related]
18. Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and H-type hypertension: A systematic review and meta-analysis. Liao S, Guo S, Ma R, He J, Yan Y, Zhang X, Wang X, Cao B, Guo H. Ann Hum Genet; 2022 Sep 01; 86(5):278-289. PubMed ID: 35394066 [Abstract] [Full Text] [Related]
19. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals. Ma C, Liu Y, Zhang W, Liu P. Mol Biol Rep; 2013 Mar 01; 40(3):2061-8. PubMed ID: 23329275 [Abstract] [Full Text] [Related]
20. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Sun H, Han B, Zhai H, Cheng X, Ma K. Tumour Biol; 2014 Jan 01; 35(1):189-93. PubMed ID: 24132589 [Abstract] [Full Text] [Related] Page: [Next] [New Search]